# GlucoTrack (GCTK) — News

GCTK · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/gctk/news

## Recent headlines

- [Glucotrack, Inc. announces pricing of $3 million public offering](https://www.ainvest.com/news/glucotrack-announces-pricing-3-million-public-offering-2609) — AInvest Wire, Sep 24, 2026
  Glucotrack, Inc. (Nasdaq: GCTK) has announced the pricing of a $3.0 million public offering of approximately 2.6 million shares of common stock at $1.15 per share. The offering, structured as a “best efforts” public offering, is expected to close on or about February 5, 2025, subject to customary…
- [Glucotrack registers to offer, resell up to 43.45M shrs](https://www.ainvest.com/news/glucotrack-registers-offer-resell-43-45m-shrs-2609) — AInvest Wire, Sep 18, 2026
  Glucotrack Inc. has filed a registration statement with the Securities and Exchange Commission to offer and resell up to 43.45 million shares of its common stock. The company has not specified the intended use of proceeds from the offering, nor has it disclosed the price range or timing for the…
- [Glucotrack announces $11.5 million financing](https://www.ainvest.com/news/glucotrack-announces-11-5-million-financing-2609) — AInvest Wire, Sep 11, 2026
  Glucotrack, Inc. (NASDAQ: GCTK) has announced a total of $11.5 million in financing over the past year, reflecting continued investor confidence in the company’s development of its continuous blood glucose monitoring (CBGM) technology. The financing includes a $2.0 million equity round priced at…
- [Glucotrack - Announces 1-for-15 reverse stock split effective August 31, 2026](https://www.ainvest.com/news/glucotrack-announces-1-15-reverse-stock-split-effective-august-31-2026-2608) — AInvest Wire, Aug 27, 2026
- [Glucotrack - enters amendment No. 1 to stock purchase agreement with White Lion Capital on Aug 7th - SEC filing](https://www.ainvest.com/news/glucotrack-enters-amendment-1-stock-purchase-agreement-white-lion-capital-aug-7th-sec-filing-2608) — AInvest Wire, Aug 10, 2026
  On August 7, 2026, Glucotrack, Inc. executed Amendment No. 1 to its Stock Purchase Agreement with White Lion Capital, as disclosed in a recent SEC filing. The amendment outlines adjustments to the original terms of the agreement, though specific details of the modifications have not been publicly…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).